Browsing
     by title


0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

or enter first few letters:   
OK
Peer Reviewed
See detailInfo-congres. La cochrane collaboration, porte-parole de la medecine factuelle.
Scheen, André ULg

in Revue Médicale de Liège (2001), 56(11), 796-8

During the 9th International Cochrane Colloquium (Lyon October 9-13, 2001), around 700 participants discussed about how to make the evidence dissemination process more efficient in order to promote the ... [more ▼]

During the 9th International Cochrane Colloquium (Lyon October 9-13, 2001), around 700 participants discussed about how to make the evidence dissemination process more efficient in order to promote the Evidence-Based Medicine. The best evidence is summarized in systematic reviews of randomised and/or controlled clinical trials within the Cochrane Library which are prepared with a high methodological quality. However, these reviews should be completed to cover all medical domains, be actualized regularly, and, most importantly, be better known and more largely used by physicians in routine practice. All these objectives could not be attained without an official recognition and a financial support by the public health authorities. [less ▲]

Detailed reference viewed: 19 (2 ULg)
Peer Reviewed
See detailInfo-congrès. Le bisoprolol dans la décompensation cardiaque
Kulbertus, Henri ULg; Pierard, Luc ULg

in Revue Médicale de Liège (1998), 53(4), 223-4

Detailed reference viewed: 10 (0 ULg)
Peer Reviewed
See detailInfo-congres. Les lecons de la "United Kingdom Prospective Diabetes Study".
Scheen, André ULg; Lefebvre, Pierre ULg

in Revue Médicale de Liège (1998), 53(9), 576-8

The United Kingdom Prospective Diabetes Study (UKPDS) is the largest study ever performed in the field of diabetes. It has been carried on in more than 5000 patients with newly diagnosed type 2 diabetes ... [more ▼]

The United Kingdom Prospective Diabetes Study (UKPDS) is the largest study ever performed in the field of diabetes. It has been carried on in more than 5000 patients with newly diagnosed type 2 diabetes and followed during almost 15 years. The main goals of the study were to investigate the effects of improving blood glucose and/or blood pressure control on diabetic complications, and to compare the advantages and inconvenients of the most important pharmacological approaches. The results of the UKPDS have been presented at the last Congress of the European Association for the Study of Diabetes (EASD) in Barcelona, September 10-11, 1998. They essentially showed that improving blood glucose or arterial blood pressure control allows to significantly reduce the incidence of complications associated to diabetes. Best results were observed in individuals in whom treatments of both hyperglycemia and hypertension were intensified. For each risk factor, no threshold has been found so that every reduction in blood glucose or arterial pressure is accompanied by a nearly linear diminution in the incidence of diabetic complications. The type of pharmacological treatment appears to have a less prominent influence, even if metformin appears to exert the most favourable effects in the group of obese patients with type 2 diabetes. [less ▲]

Detailed reference viewed: 18 (0 ULg)
Full Text
Peer Reviewed
See detailInfo-congres. Optimalisation de la prise en charge du patient diabetique: une selection de quelques essais cliniques presentes au Congres 2004 de l'American Diabetes Association.
Scheen, André ULg; Radermecker, Régis ULg; Philips, Jean-Christophe ULg

in Revue Médicale de Liège (2004), 59(6), 407-12

The 64th scientific congress of the American Diabetes Association had a special session devoted to the presentation of the results from three clinical trials: 1) the first multicentre international trial ... [more ▼]

The 64th scientific congress of the American Diabetes Association had a special session devoted to the presentation of the results from three clinical trials: 1) the first multicentre international trial of pancreatic islet transplantation according to the so-called Edmonton protocol with the primary endpoint of restoring insulin independence in type 1 diabetic patients; 2) three pivotal studies of 30 weeks testing both the efficacy and safety of exenatide (exendin-4), a new insulin secretagogue that is a long-acting analogue of glucagon-like peptide-1, in patients with type 2 diabetes treated with either metformin, or a sulfonylurea, or a metformin-sulfonylurea combination; and 3) the "Collaborative AtoRvastatin Diabetes Study" (CARDS), a placebo-controlled primary prevention trial of cardiovascular complications using atorvastatin 10 mg in 2 838 at risk patients with type 2 diabetes. The main results and conclusions of these trials are briefly presented as they open new perspectives in the management of patients with type 1 or type 2 diabetes mellitus. [less ▲]

Detailed reference viewed: 25 (3 ULg)
Full Text
Peer Reviewed
See detailInfo-congres. Prevention du diabete de type 2 chez le sujet obese: premiers resultats avec l'orlistat dans l'etude XENDOS.
Scheen, André ULg

in Revue Médicale de Liège (2002), 57(9), 617-21

The results of the XENDOS study were presented by Professor Lars Sjostrom (Gothenburg, Sweden), on August 26, 2002, at the 9th International Congress on Obesity in Sao Paulo, Brazil. XENDOS (XENical in ... [more ▼]

The results of the XENDOS study were presented by Professor Lars Sjostrom (Gothenburg, Sweden), on August 26, 2002, at the 9th International Congress on Obesity in Sao Paulo, Brazil. XENDOS (XENical in the prevention of Diabetes in Obese Subjects) is a multicentre, randomised, double-blind, placebo-controlled, parallel-group prospective study performed in Sweden over a period of 4 years. The aim of XENDOS was to investigate the use of a weight loss agent (orlistat, Xenical) compared with lifestyle changes for the prevention of type 2 diabetes in obese patients (body mass index > or = 30 kg/m2). Weight loss was greater in the orlistat group (-6.9 kg; n = 1.640) than in the placebo group (-4.1 kg; n = 1.637; p < 0.001). Such a difference in weight reduction was sufficient to significantly reduce the cumulative incidence of type 2 diabetes (6.2% versus 9.0%; p = 0.0032; relative risk reduction of 37.3%). The difference was especially remarkable in obese patients with impaired glucose tolerance (21% of the cohort), with a reduction of conversion to diabetes from 28.8% in the placebo group to 18.8% in the orlistat group (p < 0.005) and a number needed to treat to avoid one event of 11 only. Significant and sustained reductions in cardiovascular risk factors such as arterial blood pressure and lipid levels were also observed in the orlistat group as compared to the placebo group. XENDOS is the first study demonstrating that an antiobesity agent, like orlistat, is able to reduce the progression to diabetes in obese subjects as compared with lifestyle changes alone. [less ▲]

Detailed reference viewed: 179 (0 ULg)
Peer Reviewed
See detailInfo-congres. Prevention pharmacologique de la progression de la diminution de la tolerance au glucose vers le diabete de type 2: effets favorables de la metformine et de l'acarbose.
Scheen, André ULg

in Revue Médicale de Liège (2001), 56(10), 727-30

We report the positive results of two large prospective studies of pharmacological prevention of type 2 diabetes presented at the EASD Congress in Glasgow, September 12, 2001. In the "Diabetes Prevention ... [more ▼]

We report the positive results of two large prospective studies of pharmacological prevention of type 2 diabetes presented at the EASD Congress in Glasgow, September 12, 2001. In the "Diabetes Prevention Program", metformin (2 x 850 mg/day), a biguanide compound, reduces the progression from impaired glucose tolerance towards type 2 diabetes by 31% (p < 0.001) while in the "STOP-NIDDM trial", acarbose (3 x 100 mg/day), an alpha-glucosidase inhibitor, diminished it by 24% (p < 0.002). These results are, however, less marked than those obtained with lifestyle modifications including better dietary habits and increased physical exercise (-58% versus control group, p < 0.001). [less ▲]

Detailed reference viewed: 12 (0 ULg)
Peer Reviewed
See detailInfo-congres. Recherche en diabetologie: rayonnement europeen de l'Ecole de Liege.
Scheen, André ULg

in Revue Médicale de Liège (2000), 55(10), 960-7

Detailed reference viewed: 12 (1 ULg)
Full Text
See detailInfo-congrès: le congrès de l'ALFEDIAM se tenant à Bruxelles
RADERMECKER, Régis ULg

in Revue de l'Association Belge du Diabète (2008), 51

Detailed reference viewed: 10 (1 ULg)
Full Text
Peer Reviewed
See detailInformal caregiver involvement in innovative home care projects in Belgium
Lopez Hartmann; Van Durme, Thérèse; Maggi, Patrick ULg et al

Poster (2013, April)

Detailed reference viewed: 22 (1 ULg)
Full Text
Peer Reviewed
See detailInformal Networks and Start-Up Entrepreneurs in Spain: Networking Other Entrepreneurs and Angel Investors
Aliaga Isla, Rocio ULg

in Journal of CENTRUM Cathedra (2014)

This paper contributes by containing an examination of the impact of informal networks, such as personally knowing other entrepreneurs and having access to business angel investors, have upon start-up ... [more ▼]

This paper contributes by containing an examination of the impact of informal networks, such as personally knowing other entrepreneurs and having access to business angel investors, have upon start-up entrepreneurs in Spain. In addition, a pseudo-panel approach is used with micro data from the Spanish Global Entrepreneurship Monitor (GEM) adult population survey over the period 2006-2009. This technique overcomes limitations found when using cross-sectional data. Moreover, this includes a short review of literature using cross- sectional data in order to identify how researchers used these data. Results show that informal networks are important for start-up entrepreneurs. Knowing other entrepreneurs personally and having access to angel investors have a positive relationship with start-up entrepreneurs. Also, the findings indicate that start- up entrepreneurs in cohorts aged 49-58 and 59-64 do better than younger ones. Furthermore, this article highlights some implications. [less ▲]

Detailed reference viewed: 4 (0 ULg)
See detailInformation - orientation : articulation
Wouters, Chantal; Broonen, Jean-Paul ULg

in Conseil de l'Education et de la Formation. Rapport 1995-1996 (Ed.) De l'enseignement secondaire à l'enseignement supérieur : Orientation - Information (1996)

Detailed reference viewed: 13 (2 ULg)
Full Text
See detailInformation Acquisition in Repeated Relationships
Gautier, Axel ULg; Paolini, Dimitri

in Pelzer, Lawrence (Ed.) New Developments in Macroeconomics Research (2005)

This paper presents a new rationale for delegation. In a repeated relationship, when the principal gives up at time t the control over an action to the better informed agent, the decision taken by the ... [more ▼]

This paper presents a new rationale for delegation. In a repeated relationship, when the principal gives up at time t the control over an action to the better informed agent, the decision taken by the agent signals his private information to the principal. The revelation of information is valuable to the principal only in a context of repeated relation where the principal can use the information at time t + 1 to take another decision. In this paper, we present an example where delegation occurs only if the relation lasts for more than one period. In a single period context, if the agent has a bias in favor of one project, he does not have incentives to select a project that is not his preferred one; hence he does not disclose his private information and delegation is not valuable. While in a repeated relationship, it becomes costly for the agent to keep the principal non-informed and this counterbalances the agent’s bias for one project. Shared-control (partial delegation) is then the preferred organizational structure when the interaction is repeated. Moreover, shared-control dominates an alternative mechanism where the principal centralizes all the decisions and the information is transferred through a message game. [less ▲]

Detailed reference viewed: 35 (1 ULg)
Full Text
Peer Reviewed
See detailL'information basée sur un modèle biopsychosocial modifie positivement les croyances des adolescents
Henrotin, Yves ULg; Henot, B; Parmentier, I et al

in Revue du Rhumatisme (2008), 75

Detailed reference viewed: 8 (0 ULg)
Full Text
Peer Reviewed
See detailInformation behaviour of French-speaking speech–language therapists in Belgium: results of a questionnaire survey
Durieux, Nancy ULg; Pasleau, Françoise ULg; Piazza, Aurélie ULg et al

in Health Information and Libraries Journal (2016), 33

BACKGROUND: Speech–language therapists (SLTs) are encouraged to implement evidence-based practice (EBP). Nevertheless, EBP use by practitioners can be questioned. OBJECTIVES: The objective of this study ... [more ▼]

BACKGROUND: Speech–language therapists (SLTs) are encouraged to implement evidence-based practice (EBP). Nevertheless, EBP use by practitioners can be questioned. OBJECTIVES: The objective of this study was to explore Belgian French-speaking SLTs’ information behaviour and their awareness of EBP. The collected data allow one to determine how far they have embraced this approach. METHODS: The two Belgian French-speaking SLT professional associations promoted an online questionnaire survey by email. Additionally, clinical supervisors of students were asked to participate. In March 2012, 2068 emails were sent. RESULTS: The participation rate was at least 20% (n = 415). The reported information needs mainly concerned treatment or diagnosis. Most of the time, to attempt to fulfil their information needs, SLTs relied on their own resources (personal experience and libraries) and on colleagues in the workplace. When they searched on the Internet, they preferred to use a general search engine rather than a specialised bibliographic database. Barriers to obtaining scientific information are highlighted. Only 12% of the respondents had already heard about EBP. CONCLUSION: This study provides the first overview of the information behaviour of SLTs working in the French community of Belgium. Several recommendations are suggested for SLTs and librarians. [less ▲]

Detailed reference viewed: 69 (29 ULg)
Full Text
Peer Reviewed
See detailInformation delivery to patients with acute low back pain: a longitudinal observational randomized survey
Marty, M; Moyse, D; Bazin, T et al

in Annals of the Rheumatic Diseases (2009), 68(Suppl 3), 700

Detailed reference viewed: 13 (0 ULg)
Full Text
See detailL'information des feedbacks pour les professeurs : l'opération VOCA profs à l'ULg : estimation par les professeurs des résultats des étudiants au check-up de vocabulaire
Leclercq, Dieudonné ULg; Gilles, Jean-Luc ULg; Dupont, Chantal ULg

in Leclercq, Dieudonné (Ed.) Diagnostic cognitif et métacognitif au seuil de l'université : le projet Mohican menée par les 9 universités de la Communauté française Wallonie-Bruxelles (2003)

Detailed reference viewed: 20 (1 ULg)
Full Text
Peer Reviewed
See detailInformation des patients souffrant de lombalgie aigue: enquête sur les pratiques des médecins français
Marty, M; Moyse, D; Bazin, T et al

in Revue du Rhumatisme (2008), 75

Detailed reference viewed: 6 (0 ULg)
Full Text
Peer Reviewed
See detailL'information du justiciable quant aux voies de recours: lorsqu'apparaissent les lacunes d'un système
Thevissen, Patrick ULg

in Revue de Jurisprudence de Liège, Mons et Bruxelles (2009), 2009(1), 4-17

Réflexions sur les lacunes du système pénal belge en matière d'information du justiciable quant aux voies de recours disponibles à la lumière de l'enseignement de l'arrêt rendu par la Cour Européenne des ... [more ▼]

Réflexions sur les lacunes du système pénal belge en matière d'information du justiciable quant aux voies de recours disponibles à la lumière de l'enseignement de l'arrêt rendu par la Cour Européenne des Droits de l'Homme le 24 mai 2007 dans l'affaire Da Luz Dominguez Ferreira c. Belgique. [less ▲]

Detailed reference viewed: 82 (8 ULg)
Full Text
Peer Reviewed
See detailInformation du patient lombalgique : de la recherche à la pratique
Marty, Marc; Henrotin, Yves ULg

in Revue du Rhumatisme (2009), 76

Detailed reference viewed: 13 (8 ULg)